Results 211 to 220 of about 61,341 (287)

Neuroendocrinology meets addiction: Emerging pharmacotherapies on the horizon

open access: yesJournal of Internal Medicine, Volume 298, Issue 5, Page 392-423, November 2025.
Abstract Alcohol and other substance use disorders (ASUDs) are prevalent and major contributors to global morbidity and mortality. Their impact extends beyond the individual, imposing significant burdens on families, communities, healthcare systems, and society at large.
Anna Loften   +3 more
wiley   +1 more source

Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies

open access: yesThe Lancet Diabetes and Endocrinology, 2018
Anne L. Schumann   +19 more
semanticscholar   +1 more source

Effect of spironolactone on urinary excretion of immunoreactive prostaglandin E in essential hypertension and primary aldosteronism.

open access: bronze, 1978
Satoru Chiba   +8 more
openalex   +2 more sources

Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin‐diabetic rats [PDF]

open access: bronze, 2001
Goran Miric   +5 more
openalex   +1 more source

Prognostic Value of Intrarenal Venous Flow Analysis Using Pulsed‐Wave Doppler Ultrasonography in Dogs with Myxomatous Mitral Valve Disease

open access: yesJournal of Veterinary Internal Medicine, Volume 39, Issue 6, November/December 2025.
ABSTRACT Background The predictive value of intrarenal Doppler ultrasonography (IRD) analysis using pulsed‐wave Doppler for survival in dogs with myxomatous mitral valve disease (MMVD) remains unknown. Hypothesis/Objectives Impaired IRD indices, such as a high venous impedance index (VII), are associated with a short survival time in dogs with MMVD ...
Tomoya Morita   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy